Zimmer announces FDA clearance of the Optio-C anterior cervical system

167

Zimmer Spine has announced FDA 510(k) clearance of the Optio-Canterior cervical plate for use with structural allograft/autograft as a stand-alone cervical system for cervical fusion procedures. 

Zimmer says that the Optio-C system is a next-generation, modular stand-alone cervical device that offers allograft/autograft and PEEK options and delivers the strength, stability and fusion potential of a traditional anterior cervical discectomy and fusion.

“Zimmer is pleased to offer the industry’s first no profile stand-alone cervical device with structural allograft/autograft in one modular system. In follow up to the PEEK option we launched earlier this year, we have expanded the Optio-C system to include multiple materials,” comments Steve Healy, president of Zimmer Spine. “Surgeons now have a choice to use structural allograft/autograft or PEEK in their stand-alone ACDF procedures.”